A good manufacturing practice procedure to generate therapeutic numbers of highly pure anti-leukemic virus-specific T-cells

Author(s):
Loenen, M.M. van; Boer, R. de; Liempt, P.A.G. van; Hagedoorn, R.S.; Meij, P.; Falkenburg, J.H.F.; Heemskerk, M.H.M. (0000-0001-6320-9133)
Published
2012
Publication type
Article / Letter to editor
Date issued
2012-09-30
Language
English
Is part of
Immunology (2012), Vol. 137, p. 686-686
hdl
1887/97977